Global CBD Oral Smoke Market Report

CBD Oral Inhalers Market Size

According to industry forecasts, the global CBD sublingual spray market generated $133.8 million in revenue in 2022, with a projected compound annual growth rate (CAGR) of 18.9% from 2023 to 2032. It is anticipated that by 2032, the market will reach a scale of $721.8 million. In terms of product specification, sublingual sprays containing 10 to 20 milligrams of CBD are the most popular and have taken a dominant position in the market. Geographically, North America continues to be the largest revenue-generating market; on a national level, Mexico is expected to achieve the highest compound annual growth rate within the forecast period.

CBD lozenges are increasingly being positioned as part of a broader health and lifestyle initiative, highlighting the potential benefits of cannabinoids for physical relaxation, improved concentration, and overall well-being. These portable lozenge packets are considered to be advantageous for patients managing various chronic conditions such as anxiety and pain. According to a 2024 Healthline survey, 25% of American adults have used CBD products or are interested in using cannabidiol products.

The market is becoming increasingly diverse, with a variety of oral tobacco brands offering various flavors, strengths, and formulations to meet specific needs. Some products focus on relaxation and stress relief, while others emphasize energy and focus. Product customization allows consumers to tailor their CBD experience to their own requirements.

Moreover, CBD lozenge manufacturers continue to introduce new and unique flavor options, ranging from traditional mint and fruit flavors to more exotic and experimental taste profiles, in order to satisfy consumers' evolving tastes and preferences. For instance, in September 2022, the renowned CBD lozenge manufacturer Cannadips launched a new line of Cannadips Fuel pouches designed to help consumers improve sleep quality and regain vitality. This new product line offers flavors such as mint, mango, mocha, caramel, and peach, and is available across the United States through online and select retail channels.

Currently, consumers are increasingly seeking natural and alternative health solutions, and cannabis has become a viable choice due to its effects in alleviating anxiety, relieving pain, and aiding sleep.

Unlike edible products or oils, sublingual cannabis strips provide a swift and convenient way to experience the effects of CBD without the need to ingest or use cumbersome smoking tools. The discreetness and portability are especially appealing to those who wish to enjoy the benefits of cannabinoids in public places or while traveling without drawing attention. Furthermore, the versatility of cannabis sublingual strips (usable for both therapeutic and recreational purposes) has further propelled the rapid growth of the market.

In fact, CBD is popular among people of all ages. According to the Forbes 2024 Health Survey results, 32% of participants aged 18-25 are using CBD, while 90% of participants aged 77 and above also have a fondness for CBD. Ensuring the future success of CBD brands depends on attracting and retaining consumers from all age groups.

Currently, word-of-mouth marketing is the most prevalent way for consumers to first encounter CBD products, including CBD oral inhalants. As such, it is critical to guide marketing efforts towards specific target audiences through appropriate channels to enhance brand awareness, acceptance, and loyalty.

The increasing popularity of smokeless products, which have replaced traditional tobacco products, has also benefited the CBD oral smoke market. Consumers seeking healthier ways to consume nicotine or cannabis are adopting oral smoke as an ideal strategy to reduce harm.

The convenience and portability of CBD oral sprays make them an immensely attractive option. Additionally, the legalization of cannabis in multiple countries has also fostered acceptance and demand for CBD products. Legalization has made cannabis more accessible and reduced the stigma associated with its use, encouraging more consumers to explore its potential benefits.

Market Characteristics

The characteristics of the CBD oral spray market are its high level of innovation, which can be attributed to the rapid advancements in extraction technologies and the development of product formulations. Major companies are continually developing new extraction methods to enhance the bioavailability and efficacy of CBD, thereby introducing innovative products.

As established companies seek to consolidate their market position and expand their product offerings, the CBD lozenge market has also witnessed an increasing number of mergers and acquisitions. Strategic acquisitions enable companies to gain new technologies, distribution channels, and larger customer bases. With the market maturing and competition intensifying, this trend of integration is expected to continue.

The CBD lozenge market is significantly affected by regulations, with differences existing among various countries' laws. Currently, governments worldwide are actively striving to establish clear guidelines for the production, transportation, and sale of cannabis products, including lozenges. Additionally, the market is facing competition from other forms of CBD products such as tinctures, capsules, and edibles.

Although oral cannabis products offer convenience and freedom of choice, consumers may choose other types of products based on personal preferences and needs. The emergence of new methods of intake and novel cannabinoids such as CBG and CBN could also provide competition to the growth of the oral cannabis product market. The market serves a diverse consumer base, but a specific end-user group constitutes a significant portion of the demand, which includes individuals seeking relief for stress, anxiety, and sleep disorders, as well as those interested in overall health and maintaining balance in the body's endogenous cannabinoid system.

Product Content

In 2023, the 10mg-20mg segment of the market accounted for a significant share of the revenue, reaching 50.16%. Consumers are seeking convenient, discreet, and efficient ways to incorporate CBD into their daily routines, and cannabis lozenges meet all these criteria. This segment is particularly appealing to those looking for a moderate dosage, catering to both newcomers exploring the benefits of cannabis and experienced users seeking a consistent and reliable experience. The growing awareness and understanding of the potential benefits of cannabis lozenges with 10mg-20mg content (including stress relief, pain management, and improved sleep) have driven their widespread market acceptance.

It is projected that between 2024 and 2032, the compound annual growth rate for the sub-10 milligram segment will reach 23.4%. The lower dosage range of up to 10 milligrams per serving makes these products an ideal choice for cannabis novices or consumers who are just beginning to experience cannabis. The products allow users to start with a lower dose and then gradually adjust it according to their own needs and tolerance levels. The 10 milligram CBD lozenges offer a relatively easy way to experience the potential benefits of CBD without disrupting daily activities.